Search research articles
Contact Us
Filters
Showing results (331-340 of 353) with videos related to
Page
of 36
Sort By:
American Heart Journal
|
May 17, 2026
Cardiovascular Regulatory Science: Accelerating the Path from Bench to Bedside
Serge Korjian, C Michael Gibson, Jonathan Seltzer, et al.
European Heart Journal
|
May 7, 2014
Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial
A Michael Lincoff, Matthew Roe, Philip Aylward, et al.
American Heart Journal
|
December 6, 2021
Effects of long-term testosterone treatment on cardiovascular outcomes in men with hypogonadism: Rationale and design of the TRAVERSE study
Shalender Bhasin, A Michael Lincoff, Shehzad Basaria, et al.
The New England Journal of Medicine
|
November 25, 2006
Bivalirudin for patients with acute coronary syndromes
Gregg W Stone, Brent T McLaurin, David A Cox, et al.
The Lancet. Diabetes & Endocrinology
|
May 11, 2026
A comparison of the effects of tirzepatide and dulaglutide on major kidney events in people with type 2 diabetes: pre-specified exploratory analyses of the SURPASS-CVOT trial
Sophia Zoungas, David D'Alessio, Imre Pavo, et al.
JAMA
|
February 15, 2007
Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial
Gregg W Stone, Michel E Bertrand, Jeffrey W Moses, et al.
JAMA
|
November 15, 2020
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial
Stephen J Nicholls, A Michael Lincoff, Michelle Garcia, et al.
Journal of the American College of Cardiology
|
September 4, 2024
ApoA-I Infusions and Burden of Ischemic Events After Acute Myocardial Infarction: Insights From the AEGIS-II Trial
C Michael Gibson, Gerald Chi, Danielle Duffy, et al.
The New England Journal of Medicine
|
June 16, 2023
Cardiovascular Safety of Testosterone-Replacement Therapy
A Michael Lincoff, Shalender Bhasin, Panagiotis Flevaris, et al.
The New England Journal of Medicine
|
December 17, 2025
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes
Stephen J Nicholls, Imre Pavo, Deepak L Bhatt, et al.
Page
of 36
Search research articles
Search
Showing results (331-340 of 353) with videos related to
Sort By:
Page
of 36
American Heart Journal
|
May 17, 2026
Cardiovascular Regulatory Science: Accelerating the Path from Bench to Bedside
Serge Korjian, C Michael Gibson, Jonathan Seltzer, et al.
European Heart Journal
|
May 7, 2014
Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial
A Michael Lincoff, Matthew Roe, Philip Aylward, et al.
American Heart Journal
|
December 6, 2021
Effects of long-term testosterone treatment on cardiovascular outcomes in men with hypogonadism: Rationale and design of the TRAVERSE study
Shalender Bhasin, A Michael Lincoff, Shehzad Basaria, et al.
The New England Journal of Medicine
|
November 25, 2006
Bivalirudin for patients with acute coronary syndromes
Gregg W Stone, Brent T McLaurin, David A Cox, et al.
The Lancet. Diabetes & Endocrinology
|
May 11, 2026
A comparison of the effects of tirzepatide and dulaglutide on major kidney events in people with type 2 diabetes: pre-specified exploratory analyses of the SURPASS-CVOT trial
Sophia Zoungas, David D'Alessio, Imre Pavo, et al.
JAMA
|
February 15, 2007
Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial
Gregg W Stone, Michel E Bertrand, Jeffrey W Moses, et al.
JAMA
|
November 15, 2020
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial
Stephen J Nicholls, A Michael Lincoff, Michelle Garcia, et al.
Journal of the American College of Cardiology
|
September 4, 2024
ApoA-I Infusions and Burden of Ischemic Events After Acute Myocardial Infarction: Insights From the AEGIS-II Trial
C Michael Gibson, Gerald Chi, Danielle Duffy, et al.
The New England Journal of Medicine
|
June 16, 2023
Cardiovascular Safety of Testosterone-Replacement Therapy
A Michael Lincoff, Shalender Bhasin, Panagiotis Flevaris, et al.
The New England Journal of Medicine
|
December 17, 2025
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes
Stephen J Nicholls, Imre Pavo, Deepak L Bhatt, et al.
Page
of 36